Salute e Benessere
SciBase continues US expansion and will attend Fall Clinical conference
The new consensus report that was published in the JDD ( September 2024 issue) will also be presented at the 44th annual Fall Clinical Dermatology Conference ("Fall Clinical 2024"). The consensus report evaluated several technologies for melanoma diagnosis and supports the use of Nevisense for its ability to significantly enhance clinician's diagnostic assessment of atypical moles by non-invasively providing them with critical information at point of care.
"It is very encouraging to see that our recently added resources already are expanding our geographical footprint in the US, and we have recently opened up new markets in Pennsylvania , Maryland and Colorado . We are excited to continue this momentum during the Fall Clinical 2024 conference. SciBase is proud to support and attend the Fall Clinical 2024 conference and we look forward to engaging with our current customers as well as establishing new customers to further our mission of providing both clinicians and patients with improved outcomes and to positively impact the betterment of patient care.," said Pia Renaudin, CEO of SciBase.
Pia Renaudin , CEO, tel. +46732069802, e-mail:
pia.renaudin@scibase.com
Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content: https://www.prnewswire.co.uk/news-releases/scibase-continues-us-expansion-and-will-attend-fall-clinical-conference-302281470.html